Safety, Tolerability, and Pharmacodynamics of GS ‐4224 in Healthy Participants and Participants With Chronic Hepatitis B
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Liver International
DOI: 10.1111/liv.70695
Authors: Edward J. Gane, Chi‐Yi Chen, Cheng‐Hao Tseng, Chun‐Yen Lin, Stuart K. Roberts, Dana Tedesco, Frida Abramov, Fangqiu Zhang, Jared M. Odegard, Jeffrey J. Wallin, Naveed A. Shaik, Teri Chew, Latesh Lad, Adele Y. Wang, Scott Balsitis, Simon P. Fletcher, Audrey H. Lau, Wan‐Long Chuang, Kosh Agarwal
Institutions: University of Auckland, Chia-Yi Christian Hospital, E-Da Hospital, Chang Gung University, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, The Alfred Hospital, Monash University, Gilead Sciences (United States), Kaohsiung Medical University, Kaohsiung Medical University Chung-Ho Memorial Hospital, King's College Hospital NHS Foundation Trust, King's College Hospital
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Gilead Sciences
OpenAlex ID: W7162005591